From acute diagnosis to longitudinal risk stratification: a paradigm shift in the clinical role of cardiac biomarkers
Frontiers in Cardiovascular Medicine · 13.03.2026 · 13
DOI: 10.3389/fcvm.2026.1778456 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 13.03.2026. Verfasst von Hong Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, China. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This perspective examines the evolving role of cardiac biomarkers from acute diagnostic tools to integral components of longitudinal risk stratification and cardiovascular disease management. Evidence from cohort studies, clinical trials, and high-sensitivity assays demonstrates that biomarkers reflecting myocardial injury, hemodynamic stress, inflammation, fibrosis, and metabolic dysfunction can inform prevention, early detection, acute care, and chronic monitoring. Key implementation strategies include multi-biomarker panels, serial measurements, multi-omics integration, and artificial intelligence-based risk modeling. Challenges such as assay standardization, clinical interpretation, and cost-effectiveness are critically evaluated. Overall, this framework highlights the potential for biomarker-guided approaches to promote more preventive, precise, and patient-centered cardiovascular care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, China.
- Department of Gastroenterology and Digestive Endoscopy Center, The Second Hospital of Jilin University, Changchun, China.
- Administrative Office, The First Clinical Hospital of Jilin Provincial Academy of Chinese Medicine Sciences, Changchun, China.
- Department of Geriatrics, The First Hospital of Jilin University, Changchun, China.
- Cardiology Center, The Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, China.
Zitieren
APA
Zheng, H., Li, X., Guo, L. J., Ji, G. L., Liu, H. T., Zheng, Y., & Zhou, J. (2026). From acute diagnosis to longitudinal risk stratification: a paradigm shift in the clinical role of cardiac biomarkers. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1778456
Vancouver
Zheng H, Li X, Guo LJ, Ji GL, Liu HT, Zheng Y, et al. From acute diagnosis to longitudinal risk stratification: a paradigm shift in the clinical role of cardiac biomarkers. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1778456
BibTeX
@article{Zheng2026,
author = {Zheng, Hong and Li, Xue and Guo, Li-Jiao and Ji, Guang-Ling and Liu, Hong-Tao and Zheng, Yue and Zhou, Jie},
title = {From acute diagnosis to longitudinal risk stratification: a paradigm shift in the clinical role of cardiac biomarkers},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1778456}
}
EUVIMED